Streptococcal toxic shock syndrome (STSS). An update: a roundtable presentation.
Holm
S E
SE
Köhler
W
W
Kaplan
E L
EL
Schlievert
P M
PM
Alouf
J E
JE
Stevens
D L
DL
Kotb
M
M
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001426:Bacterial Proteins; D015981:Epidemiologic Factors; D005098:Exotoxins / Q000737:chemistry / Q000633:toxicity; D049670:History, 17th Century; D049671:History, 18th Century; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008565:Membrane Proteins; D012772:Shock, Septic / Q000209:etiology / Q000266:history / Q000628:therapy; D013290:Streptococcal Infections / Q000209:etiology / Q000266:history / Q000628:therapy; D013297:Streptococcus pyogenes / Q000472:pathogenicity; D018089:Superantigens / Q000737:chemistry / Q000633:toxicity
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D005098:Exotoxins; D016756:Immunoglobulins, Intravenous; D008565:Membrane Proteins; C117980:SpeA protein, Streptococcus pyogenes; D018089:Superantigens; C027951:erythrogenic toxin